Remember meForgot password?
    Log in with Twitter
Blog In Health

Counterfeit cancer medication in the US

By Tim Sandle
Posted Apr 4, 2012 in Health
The US FDA have announced that its lab tests have confirmed that a counterfeit version of the pharma company Roche’s Altuzan 400mg/16ml (bevacizumab),an injectable cancer medication, found in the U.S. contains no active ingredient. Even if the identified drugs were not counterfeit, Altuzan is not approved by FDA for use in the United States (it is an approved drug in Turkey).
Medical practices obtained the counterfeit Altuzan and other unapproved products through foreign sources, in particular from Richards Pharma, also known as Richards Services, Warwick Healthcare Solutions, or Ban Dune Marketing Inc (BDMI). Many, if not all, of the products sold and distributed through this distributor have not been approved by the FDA. Pictures of the counterfeit version of Altuzan are shown in the FDA statement. Packaging or vials found in the U.S. that claim to be Roche’s Altuzan with lot number B6021 should be considered counterfeit.
For further details, see FDA Medwatch

More about Cancer, Counterfeit, Drugs
Latest News
Top News